Mechanistic and dose considerations for supporting adverse pulmonary physiology in response to formaldehyde

Toxicology and Applied Pharmacology

Volumn 233, Issue 3, 2008, Pages 355-359

  Thompson, Chad M ^a   Subramaniam, Ravi P ^a   Grafström, Roland C ^b,c  

^a U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

^b KAROLINSKA INSTITUTE   (Sweden)

^c VTT TECHNICAL RESEARCH CENTRE OF FINLAND   (Finland)

Author keywords

ADH3; Asthma; Dosimetry; Formaldehyde; S nitrosoglutathione

Indexed keywords

FORMALDEHYDE; S NITROSOGLUTATHIONE;

ASTHMA; BRONCHUS HYPERREACTIVITY; CONCENTRATION RESPONSE; HUMAN; NONHUMAN; PATHOPHYSIOLOGY; PNEUMONIA; REDUCTION; REVIEW; RISK ASSESSMENT; TH2 CELL;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; FORMALDEHYDE; HUMANS; IRRITANTS; RESPIRATORY HYPERSENSITIVITY; RESPIRATORY PHYSIOLOGICAL PROCESSES; RISK ASSESSMENT; S-NITROSOGLUTATHIONE; TH2 CELLS;

EID: 56549096775     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2008.09.011     Document Type: Review

References (78)

1. Allison M.E., and Fearon D.T. Enhanced immunogenicity of aldehyde-bearing antigens: a possible link between innate and adaptive immunity. Eur. J. Immunol. 30 (2000) 2881-2887
2. Arts J.H., Rennen M.A., and de H.C. Inhaled formaldehyde: evaluation of sensory irritation in relation to carcinogenicity. Regul. Toxicol. Pharmacol. 44 (2006) 144-160
3. Barnes P.J. Neurogenic inflammation in the airways. Respir. Physiol. 125 (2001) 145-154
4. Barnes P.J. Immunology of asthma and chronic obstructive pulmonary disease. Nat. Rev. Immunol. 8 (2008) 183-192
5. Barnes P.J., Chung K.F., and Page C.P. Inflammatory mediators of asthma: an update. Pharmacol. Rev. 50 (1998) 515-596
6. Bender J. The use of noncancer endpoints as a basis for establishing a reference concentration for formaldehyde. Regul. Toxicol. Pharmacol. 35 (2002) 23-31
7. Bouchard M., Brunet R.C., Droz P.O., and Carrier G. A biologically based dynamic model for predicting the disposition of methanol and its metabolites in animals and humans. Toxicol. Sci. 64 (2001) 169-184
8. Brochu P., Ducre-Robitaille J.F., and Brodeur J. Physiological daily inhalation rates for free-living individuals aged 1 month to 96 years, using data from doubly labeled water measurements: a proposal for air quality criteria, standard calculations and health risk assessment. Hum. Ecol. Risk Assess. 12 (2006) 675-701
9. Butler C.A., and Heaney L.G. Neurogenic inflammation and asthma. Inflamm. Allergy Drug Targets 6 (2007) 127-132
10. Carraro S., Doherty J., Zaman K., Gainov I., Turner R., Vaughan J., Hunt J.F., Marquez J., and Gaston B. S-nitrosothiols regulate cell-surface pH buffering by airway epithelial cells during the human immune response to rhinovirus. Am. J. Physiol. Lung Cell Mol. Physiol. 290 (2006) L827-L832
11. Casanova M., and Heck H.A. Lack of evidence for the involvement of formaldehyde in the hepatocarcinogenicity of methyl tertiary-butyl ether in CD-1 mice. Chem. Biol. Interact 105 (1997) 131-143
12. Casanova M., Morgan K.T., Steinhagen W.H., Everitt J.I., Popp J.A., and Heck H.D. Covalent binding of inhaled formaldehyde to DNA in the respiratory tract of rhesus monkeys: pharmacokinetics, rat-to-monkey interspecies scaling, and extrapolation to man. Fundam. Appl. Toxicol. 17 (1991) 409-428
13. Casset A., Marchand C., Purohit A., le C.S., Uring-Lambert B., Donnay C., Meyer P., and de B.F. Inhaled formaldehyde exposure: effect on bronchial response to mite allergen in sensitized asthma patients. Allergy 61 (2006) 1344-1350
14. Chang J.C., Steinhagen W.H., and Barrow C.S. Effect of single or repeated formaldehyde exposure on minute volume of B6C3F1 mice and F-344 rats. Toxicol. Appl. Pharmacol. 61 (1981) 451-459
15. Coon R.A., Jones R.A., Jenkins Jr. L.J., and Siegel J. Animal inhalation studies on ammonia, ethylene glycol, formaldehyde, dimethylamine, and ethanol. Toxicol. Appl. Pharmacol. 16 (1970) 646-655
16. Estonius M., Svensson S., and Hoog J.O. Alcohol dehydrogenase in human tissues: localisation of transcripts coding for five classes of the enzyme. FEBS Lett. 397 (1996) 338-342
17. Ezratty V., Bonay M., Neukirch C., Orset-Guillossou G., Dehoux M., Koscielny S., Cabanes P.A., Lambrozo J., and Aubier M. Effect of formaldehyde on asthmatic response to inhaled allergen challenge. Environ. Health Perspect. 115 (2007) 210-214
18. Franklin P., Dingle P., and Stick S. Raised exhaled nitric oxide in healthy children is associated with domestic formaldehyde levels. Am. J. Respir. Crit. Care Med. 161 (2000) 1757-1759
19. Frederick C.B., Bush M.L., Lomax L.G., Black K.A., Finch L., Kimbell J.S., Morgan K.T., Subramaniam R.P., Morris J.B., and Ultman J.S. Application of a hybrid computational fluid dynamics and physiologically based inhalation model for interspecies dosimetry extrapolation of acidic vapors in the upper airways. Toxicol. Appl. Pharmacol. 152 (1998) 211-231
20. Frederick C.B., Gentry P.R., Bush M.L., Lomax L.G., Black K.A., Finch L., Kimbell J.S., Morgan K.T., Subramaniam R.P., Morris J.B., and Ultman J.S. A hybrid computational fluid dynamics and physiologically based pharmacokinetic model for comparison of predicted tissue concentrations of acrylic acid and other vapors in the rat and human nasal cavities following inhalation exposure. Inhal. Toxicol. 13 (2001) 359-376
21. Frederick C.B., Lomax L.G., Black K.A., Finch L., Scribner H.E., Kimbell J.S., Morgan K.T., Subramaniam R.P., and Morris J.B. Use of a hybrid computational fluid dynamics and physiologically based inhalation model for interspecies dosimetry comparisons of ester vapors. Toxicol. Appl. Pharmacol. 183 (2002) 23-40
22. Fujimaki H., Kurokawa Y., Kunugita N., Kikuchi M., Sato F., and Arashidani K. Differential immunogenic and neurogenic inflammatory responses in an allergic mouse model exposed to low levels of formaldehyde. Toxicology 197 (2004) 1-13
23. Garrett M.H., Hooper M.A., Hooper B.M., Rayment P.R., and Abramson M.J. Increased risk of allergy in children due to formaldehyde exposure in homes. Allergy 54 (1999) 330-337
24. Gaston B., Reilly J., Drazen J.M., Fackler J., Ramdev P., Arnelle D., Mullins M.E., Sugarbaker D.J., Chee C., and Singel D.J. Endogenous nitrogen oxides and bronchodilator S-nitrosothiols in human airways. Proc. Natl. Acad. Sci. U. S. A. 90 (1993) 10957-10961
25. Gaston B., Drazen J.M., Jansen A., Sugarbaker D.A., Loscalzo J., Richards W., and Stamler J.S. Relaxation of human bronchial smooth muscle by S-nitrosothiols in vitro. J. Pharmacol. Exp. Ther. 268 (1994) 978-984
26. Gaston B., Kelly R., Urban P., Liu L., Henderson E.M., Doctor A., Teague W.G., Fitzpatrick A., Erzurum S., and Hunt J.F. Buffering airway acid decreases exhaled nitric oxide in asthma. J. Allergy Clin. Immunol. 118 (2006) 817-822
27. Gentry P.R., Haber L.T., McDonald T.B., Zhao Q., Covington T., Nance P., Clewell III H.J., Lipscomb J.C., and Barton H.A. Data for physiologically based pharmacokinetic modeling in neonatal animals: physiological parameters in mice and Sprague-Dawley rats. J. Chilren's Health 2 (2004) 363-411
28. Gerard C. Biomedicine. Asthmatics breathe easier when it's SNO-ing. Science 308 (2005) 1560-1561
29. Ginsberg G.L., Foos B.P., and Firestone M.P. Review and analysis of inhalation dosimetry methods for application to children's risk assessment. J. Toxicol. Environ. Health A68 (2005) 573-615
30. Ginsberg G.L., Asgharian B., Kimbell J.S., Ultman J.S., and Jarabek A.M. Modeling approaches for estimating the dosimetry of inhaled toxicants in children. J. Toxicol. Environ. Health A71 (2008) 166-195
31. Gordon C.J., Spencer P.J., Hotchkiss J., Miller D.B., Hinderliter P.M., and Pauluhn J. Thermoregulation and its influence on toxicity assessment. Toxicology 244 (2008) 87-97
32. Hauptmann M., Lubin J.H., Stewart P.A., Hayes R.B., and Blair A. Mortality from lymphohematopoietic malignancies among workers in formaldehyde industries. J. Natl. Cancer Inst. 95 (2003) 1615-1623
33. Hauptmann M., Lubin J.H., Stewart P.A., Hayes R.B., and Blair A. Mortality from solid cancers among workers in formaldehyde industries. Am. J. Epidemiol. 159 (2004) 1117-1130
34. Heck H.D., Casanova M., and Starr T.B. Formaldehyde toxicity-new understanding. Crit. Rev. Toxicol. 20 (1990) 397-426
35. Hedberg J.J., Griffiths W.J., Nilsson S.J., and Hoog J.O. Reduction of S-nitrosoglutathione by human alcohol dehydrogenase 3 is an irreversible reaction as analysed by electrospray mass spectrometry. Eur. J. Biochem. 270 (2003) 1249-1256
36. Henderson E.M., and Gaston B. SNOR and wheeze: the asthma enzyme?. Trends Mol. Med. 11 (2005) 481-484
37. Hoog J.O., Stromberg P., Hedberg J.J., and Griffiths W.J. The mammalian alcohol dehydrogenases interact in several metabolic pathways. Chem. Biol. Interact. 143-144 (2003) 175-181
38. Hunt J.F., Fang K., Malik R., Snyder A., Malhotra N., Platts-Mills T.A., and Gaston B. Endogenous airway acidification. Implications for asthma pathophysiology. Am. J. Respir. Crit. Care Med. 161 (2000) 694-699
39. IARC. Formaldehyde, 2-Butoxyethanol and 1-tert-Butoxypropan-2-ol (2006), IARC, Lyon
40. Im H., Oh E., Mun J., Khim J.Y., Lee E., Kang H.S., Kim E., Kim H., Won N.H., Kim Y.H., Jung W.W., and Sul D. Evaluation of toxicological monitoring markers using proteomic analysis in rats exposed to formaldehyde. J. Proteome. Res. 5 (2006) 1354-1366
41. Jeffery P.K., and Haahtela T. Allergic rhinitis and asthma: inflammation in a one-airway condition. BMC Pulm. Med. 6 Suppl. 1 (2006) S5
42. Jensen D.E., Belka G.K., and Du Bois G.C. S-Nitrosoglutathione is a substrate for rat alcohol dehydrogenase class III isoenzyme. Biochem. J. 331 Pt 2 (1998) 659-668
43. Jung W.W., Kim E.M., Lee E.H., Yun H.J., Ju H.R., Jeong M.J., Hwang K.W., Sul D., and Kang H.S. Formaldehyde exposure induces airway inflammation by increasing eosinophil infiltrations through the regulation of reactive oxygen species production. Environ. Toxicol. Pharmacol. 24 (2007) 174-182
44. Kerns W.D., Pavkov K.L., Donofrio D.J., Gralla E.J., and Swenberg J.A. Carcinogenicity of formaldehyde in rats and mice after long-term inhalation exposure. Cancer Res. 43 (1983) 4382-4392
45. Kimbell J.S., Subramaniam R.P., Gross E.A., Schlosser P.M., and Morgan K.T. Dosimetry modeling of inhaled formaldehyde: comparisons of local flux predictions in the rat, monkey, and human nasal passages. Toxicol. Sci. 64 (2001) 100-110
46. Kips J.C., Anderson G.P., Fredberg J.J., Herz U., Inman M.D., Jordana M., Kemeny D.M., Lotvall J., Pauwels R.A., Plopper C.G., Schmidt D., Sterk P.J., Van Oosterhout A.J., Vargaftig B.B., and Chung K.F. Murine models of asthma. Eur. Respir. J. 22 (2003) 374-382
47. Koivusalo M., Baumann M., and Uotila L. Evidence for the identity of glutathione-dependent formaldehyde dehydrogenase and class III alcohol dehydrogenase. FEBS Lett. 257 (1989) 105-109
48. Krakowiak A., Gorski P., Pazdrak K., and Ruta U. Airway response to formaldehyde inhalation in asthmatic subjects with suspected respiratory formaldehyde sensitization. Am. J. Ind. Med. 33 (1998) 274-281
49. Kraneveld A.D., and Nijkamp F.P. Tachykinins and neuro-immune interactions in asthma. Int. Immunopharmacol. 1 (2001) 1629-1650
50. Lagergard T., Lundqvist A., Wising C., Gabrielsson V., and Ahlman K. Formaldehyde treatment increases the immunogenicity and decreases the toxicity of Haemophilus ducreyi cytolethal distending toxin. Vaccine 25 (2007) 3606-3614
51. Leikauf G.D. Hazardous air pollutants and asthma. Environ. Health Perspect. 110 Suppl. 4 (2002) 505-526
52. Li H., Wang J., Konig R., Ansari G.A., and Khan M.F. Formaldehyde-protein conjugate-specific antibodies in rats exposed to formaldehyde. J. Toxicol. Environ. Health A70 (2007) 1071-1075
53. Liu L., Hausladen A., Zeng M., Que L., Heitman J., and Stamler J.S. A metabolic enzyme for S-nitrosothiol conserved from bacteria to humans. Nature 410 (2001) 490-494
54. Liu L., Yan Y., Zeng M., Zhang J., Hanes M.A., Ahearn G., McMahon T.J., Dickfeld T., Marshall H.E., Que L.G., and Stamler J.S. Essential roles of S-nitrosothiols in vascular homeostasis and endotoxic shock. Cell 116 (2004) 617-628
55. Menaché M.G., Hofmann W., Ashgarian B., and Miller F.J. Airway geometry models of children's lungs for use in dosimetry modeling. Inhal. Toxicol. 20 (2008) 101-126
56. Metz B., Kersten G.F., Hoogerhout P., Brugghe H.F., Timmermans H.A., de J.A., Meiring H., ten H.J., Hennink W.E., Crommelin D.J., and Jiskoot W. Identification of formaldehyde-induced modifications in proteins: reactions with model peptides. J. Biol. Chem. 279 (2004) 6235-6243
57. Moghaddam A., Olszewska W., Wang B., Tregoning J.S., Helson R., Sattentau Q.J., and Openshaw P.J. A potential molecular mechanism for hypersensitivity caused by formalin-inactivated vaccines. Nat. Med. 12 (2006) 905-907
58. Monticello T.M., Morgan K.T., Everitt J.I., and Popp J.A. Effects of formaldehyde gas on the respiratory tract of rhesus monkeys. Pathology and cell proliferation. Am. J. Pathol. 134 (1989) 515-527
59. Monticello T.M., Miller F.J., and Morgan K.T. Regional increases in rat nasal epithelial cell proliferation following acute and subchronic inhalation of formaldehyde. Toxicol. Appl. Pharmacol. 111 (1991) 409-421
60. Nielsen G.D., Hougaard K.S., Larsen S.T., Hammer M., Wolkoff P., Clausen P.A., Wilkins C.K., and Alarie Y. Acute airway effects of formaldehyde and ozone in BALB/c mice. Hum. Exp. Toxicol. 18 (1999) 400-409
61. Overton J.H., Kimbell J.S., and Miller F.J. Dosimetry modeling of inhaled formaldehyde: the human respiratory tract. Toxicol. Sci. 64 (2001) 122-134
62. Patterson D.L., Gross E.A., Bogdanffy M.S., and Morgan K.T. Retention of formaldehyde gas by the nasal passages of F-344 rats. Toxicologist 6 (1986) 55
63. Pauluhn J. Overview of testing methods used in inhalation toxicity: from facts to artifacts. Toxicol. Lett. 140-141 (2003) 183-193
64. Paustenbach D., Alarie Y., Kulle T., Schachter N., Smith R., Swenberg J., Witschi H., and Horowitz S.B. A recommended occupational exposure limit for formaldehyde based on irritation. J. Toxicol. Environ. Health 50 (1997) 217-263
65. Pinkerton K.E., and Joad J.P. The mammalian respiratory system and critical windows of exposure for children's health. Environ. Health Perspect. 108 Suppl. 3 (2000) 457-462
66. Pinkerton L.E., Hein M.J., and Stayner L.T. Mortality among a cohort of garment workers exposed to formaldehyde: an update. Occup. Environ. Med. 61 (2004) 193-200
67. Que L.G., Liu L., Yan Y., Whitehead G.S., Gavett S.H., Schwartz D.A., and Stamler J.S. Protection from experimental asthma by an endogenous bronchodilator. Science 308 (2005) 1618-1621
68. Rumchev K.B., Spickett J.T., Bulsara M.K., Phillips M.R., and Stick S.M. Domestic exposure to formaldehyde significantly increases the risk of asthma in young children. Eur. Respir. J. 20 (2002) 403-408
69. Snyder A.H., McPherson M.E., Hunt J.F., Johnson M., Stamler J.S., and Gaston B. Acute effects of aerosolized S-nitrosoglutathione in cystic fibrosis. Am. J. Respir. Crit. Care Med. 165 (2002) 922-926
70. Staab C.A., Alander J., Brandt M., Lengqvist J., Morgenstern R., Grafstrom R.C., and Hoog J.O. Reduction of S-nitrosoglutathione by alcohol dehydrogenase 3 is facilitated by substrate alcohols via direct cofactor recycling and results in GSH-controlled formation of glutathione transferase inhibitors. Biochem. J. 413 (2008) 493-504
71. Stamler J.S., and Toone E.J. The decomposition of thionitrites. Curr. Opin. Chem. Biol. 6 (2002) 779-785
72. Teng S., Beard K., Pourahmad J., Moridani M., Easson E., Poon R., O, and Brien P.J. The formaldehyde metabolic detoxification enzyme systems and molecular cytotoxic mechanism in isolated rat hepatocytes. Chem. Biol. Interact. 130-132 (2001) 285-296
73. Thompson C.M., and Grafstrom R.C. Mechanistic considerations for formaldehyde-induced bronchoconstriction involving S-nitrosoglutathione reductase. J. Toxicol. Environ. Health A71 (2008) 244-248
74. Togias A. Systemic effects of local allergic disease. J. Allergy Clin. Immunol. 113 (2004) S8-S14
75. USEPA. Methods for derivation of inhalation reference concentrations and application of inhalation dosimetry. EPA/600/8-90/066F (1994), Office of Health and Environmental Assessment, Cincinnati, OH Ref Type: Report
76. Van Schoor J., Joos G.F., and Pauwels R.A. Indirect bronchial hyperresponsiveness in asthma: mechanisms, pharmacology and implications for clinical research. Eur. Respir. J. 16 (2000) 514-533
77. Whalen E.J., Foster M.W., Matsumoto A., Ozawa K., Violin J.D., Que L.G., Nelson C.D., Benhar M., Keys J.R., Rockman H.A., Koch W.J., Daaka Y., Lefkowitz R.J., and Stamler J.S. Regulation of beta-adrenergic receptor signaling by S-nitrosylation of G-protein-coupled receptor kinase 2. Cell 129 (2007) 511-522
78. Wu H., Romieu I., Sienra-Monge J.J., Estela D.R.N., Anderson D.M., Jenchura C.A., Li H., Ramirez-Aguilar M., Del I C.L.S., and London S.J. Genetic variation in S-nitrosoglutathione reductase (GSNOR) and childhood asthma. J. Allergy Clin. Immunol. 120 (2007) 322-328